DIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINER (calcium chloride) · VANTIVE US HLTHCARE
Ringer’s Injection helps patients by providing a necessary source of water and electrolytes. It is used for both adult and pediatric populations who require fluid replenishment and mineral support. This solution is typically prescribed to maintain proper hydration and ensure the body has the essential ions needed for various physiological processes.
How DIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINER Works
This injection works by supplying essential electrolytes that regulate the body's internal environment. Sodium and chloride help manage fluid distribution and acid-base balance, while potassium supports nerve conduction and muscle function, particularly in the heart. Additionally, the ionized calcium in the solution is vital for blood clotting, cardiac performance, and regulating neuromuscular activity.
Details
- Status
- Prescription
- First Approved
- 1978-09-27
- Routes
- INTRAPERITONEAL
- Dosage Forms
- SOLUTION
Companies
DIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINER Approval History
What DIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINER Treats
2 indicationsDIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINER is approved for 2 conditions since its original approval in 1978. These indications span multiple therapeutic areas including oncology, immunology, and more.
Drugs Similar to DIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINER
3 of 19FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Clinical Trial Registry
7 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT07550413 | 20042026 | Ph 2 | not yet recruiting | Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section |
| NCT03772990 ICARUS | 21/2019 | Ph 4 | completed | Calcium Administration in Cardiac Surgery |
| NCT05027048 CALBLOC results posted | 62206 MRTG-02-15-2022-Ansari, YIG-2020 | Ph 3 | completed | Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery |
| NCT04153435 COCA results posted | 00002 2019-003387-46 | Ph 2 | completed | Calcium for Out-of-Hospital Cardiac Arrest |
| NCT03867383 results posted | 43076 | Ph 1, Ph 2 | completed | Calcium Chloride for Prevention of Uterine Atony During Cesarean |
| NCT01941914 | AA1310 | Ph 1 | completed | Calcium Electroporation for the Treatment of Keloids |
| NCT00955266 results posted | 2009-P-000052 | Ph 4 | terminated | A Trial of Intravenous Calcium and Myocardial Diastolic Dysfunction During Separation From Cardiopulmonary Bypass |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
DIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINER FDA Label Details
Indications & Usage
FDA Label (PDF)Ringer’s Injection is indicated for use as a source of water and electrolytes in adults and pediatric patients. Ringer’s Injection is indicated for use as a source of water and electrolytes in adults and pediatric patients.
Track DIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINER with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.